Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SWHFX vs HRTS overlap: 57% of top holdings shared

Bottom line

How much do SWHFX and HRTS overlap?

57% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 57.0% of SWHFX's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

SWHFXHRTS
Weight overlap (top 25)57%
Shared holdings14
Weight in shared holdings57.0%51.9%
Total positions8045
Expense ratio0.8%0.75%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings SWHFX and HRTS have in common

Holding% of SWHFX% of HRTSOverlap
Eli Lilly & Co13.92%11.52%11.52%
Johnson & Johnson6.94%3.59%3.59%
AbbVie Inc5.81%2.40%2.40%
Merck & Co Inc4.98%4.27%4.27%
UnitedHealth Group Inc4.74%5.24%4.74%
Gilead Sciences Inc3.24%3.43%3.24%
Novartis AG2.92%3.38%2.92%
Amgen Inc2.58%1.91%1.91%
Bristol-Myers Squibb Co2.44%2.09%2.09%
Medtronic PLC2.29%1.88%1.88%
Thermo Fisher Scientific Inc2.16%3.97%2.16%
Vertex Pharmaceuticals Inc1.89%2.93%1.89%
Abbott Laboratories1.60%2.61%1.60%
Danaher Corp1.47%2.66%1.47%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SWHFX

  1. Roche Holding AG — 2.29%
  2. Stryker Corp — 2.11%
  3. Gsk Plc — 1.73%
  4. Boston Scientific Corp — 1.60%
  5. Cigna Group/The — 1.51%
  6. Elevance Health Inc — 1.45%
  7. Incyte Corp — 1.37%
  8. Ipsen SA — 1.34%
  9. Sanofi SA — 1.31%
  10. Becton Dickinson & Co — 1.24%
  11. Astellas Pharma Inc — 1.19%

Only in HRTS

  1. Novo Nordisk A/S — 5.24%
  2. Roche Holding AG — 4.50%
  3. AstraZeneca PLC — 4.00%
  4. Revolution Medicines Inc — 3.33%
  5. Bridgebio Pharma Inc — 2.59%
  6. Cytokinetics Inc — 2.52%
  7. Teva Pharmaceutical Industries — 2.06%
  8. Dexcom Inc — 1.92%
  9. Edwards Lifesciences Corp — 1.75%
  10. McKesson Corp — 1.71%
  11. Regeneron Pharmaceuticals Inc — 1.67%

Asset mix

Asset typeSWHFXHRTS
Stocks99.0%99.2%
Cash & short-term funds—0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountrySWHFXHRTS
US78.6%74.9%
CH5.2%7.9%
DK0.7%7.0%
IE4.5%1.9%
GB3.4%4.0%
FR2.6%—
JP2.3%1.3%
IL—2.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do SWHFX and HRTS overlap?
About 57% by weight. 14 securities appear in both funds' top 25 holdings; they make up 57.0% of SWHFX's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SWHFX and HRTS have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Merck & Co Inc, Johnson & Johnson, Gilead Sciences Inc.
Should I own both SWHFX and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SWHFX or HRTS?
SWHFX is broader, with 80 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.